Bishop Hans Edgar 4

What Happened
Hans Edgar, a director of Sana Biotechnology (SANA), received an award of 6,297 shares on 2026-07-06. The filing reports the acquisition as an award/grant (transaction code A) at $0.00 per share (total reported value $0). Footnotes indicate these are fully vested restricted stock units (RSUs).

Key Details

• Transaction date: 2026-07-06; filing date: 2026-07-07 (timely filing).
• Transaction type/code: Award/Grant (A).
• Shares acquired: 6,297 RSUs; reported price: $0.00; reported total value: $0.
• Footnote: F1 — consists of fully vested restricted stock units.
• Shares owned after transaction: not disclosed in this Form 4.
• No 10b5-1 plan, sale, or option exercise reported in this filing.

Context
Fully vested RSUs convert to shares without additional vesting conditions; this is a compensation award rather than an open-market purchase or sale. Such awards are common for directors and reflect grant-based compensation rather than a direct bullish cash purchase; they don’t by themselves indicate a trading decision.